IP Library Granted Patent US 9,351,492
Granted Patent B2
US 9,351,492 · App. 14/243,406 · Granted May 31, 2016

Anti-biofilm compositions and methods for using

Inventors: Cassandra L. Quave (Little Rock, AR); Mark S. Smeltzer (Little Rock, AR); Cesar M. Compadre (Little Rock, AR); Howard Hendrickson (Little Rock, AR)
Assignee: BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS
A01N43/90A01N65/00A01N65/34A61K31/19A61K31/192A61K31/352A61K31/366A61K31/43A61K31/431A61K31/496A61K31/65A61K31/7048A61K31/7056A61K36/185A61K36/21A61K36/23A61K36/24A61K36/28A61K36/40A61K36/45A61K36/48A61K36/49A61K36/51A61K36/52A61K36/53A61K36/57A61K36/61A61K36/73A61K36/75A61K36/76A61K36/77A61K36/87A61K36/88A61K36/896A61K38/12A61K38/14A61K38/15
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,351,492
App. No.
14/243,406
Granted
May 31, 2016
Kind
B2
Abstract

The present invention provides polyphenolic compositions derived from a plant that inhibit the formation of a biofilm. Also provided are combinations that comprise at least one phenolic phytochemical and at least one antimicrobial agent that inhibit the growth of an established biofilm. Further, the present invention provides methods for inhibiting the formation and growth of biofilms.

Claims (8)

1. A medical device having a coating comprising a polyphenolic composition comprising at least one glycosylated derivative of ellagic acid chosen from ellagic acid xylofuranoside, ellagic acid mannopyranoside, ellagic acid rhamnoside, or combination thereof.

2. The medical device of claim 1 , wherein the polyphenolic composition further comprises ellagic acid.

3. The medical device of claim 2 , wherein the polyphenolic composition further comprises at least one sapogenin.

4. The medical device of claim 1 , wherein the medical device is an implantable medical device.

5. The medical device of claim 4 , wherein the implantable medical device is chosen from a catheter, a cardiac device, an orthopedic device, a breathing tube, or a feeding tube.

6. The medical device of claim 1 , wherein the coating further comprises an antimicrobial agent chosen from an antibiotic, an antifungal agent, or an antiseptic.

7. The medical device of claim 6 , wherein the antimicrobial agent is an antibiotic chosen from amphotericin B, clindamycin, daptomycin, dicloxicillin, minocycline, nafcillin, oxacillin, ramoplanin, rifampin, triclosan, or vancomycin.

8. The medical device of claim 1 , wherein the coating comprises a hydrogel.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 4, 2018
From: BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS
To: BIOVENTURES, LLC
Reel/Frame 047667/0515 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR: SMELTZER, MARK A. SHOULD BE SMELTZER, MARK S. PREVIOUSLY RECORDED ON REEL 032611 FRAME 0610. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jul 9, 2014
From: QUAVE, CASSANDRA L.; SMELTZER, MARK S.; COMPADRE, CESAR M.; HENDRICKSON, HOWARD
To: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS
Reel/Frame 033282/0514 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 5, 2014
From: QUAVE, CASSANDRA L.; SMELTZER, MARK A.; COMPADRE, CESAR M.; HENDRICKSON, HOWARD
To: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS
Reel/Frame 032611/0610 →
Continuity (4)
Division 13267696 · Oct 6, 2011
Provisional Application 61488878 · May 23, 2011
Provisional Application 61390254 · Oct 6, 2010
Related Publication 20140271777A1 · Sep 18, 2014